PhD in Continuous Manufacturing and Advanced Crystallisation
CMAC, the EPSRC Future Manufacturing Research Hub in Continuous Manufacturing and Advanced Crystallisation (http://www.cmac.ac.uk), is a major initiative that aims to accelerate the adoption of continuous manufacturing technologies for high value chemical products such as pharmaceuticals.
PhD Studentship: Sustainable fuels and chemicals from the integrated conversion of biowastes
Dr J Wagner
17 January 2019
Loughborough University is a top-ten rated university in England for research intensity (REF2014) and an outstanding 66% of the work of Loughborough’s academic staff who were eligible to be submitted to the REF was judged as ‘world-leading’ or ‘internationally excellent’, compared to a national average figure of 43%.
3D Nanozymes: Fabrication and assembly of the first hybrid enzymes
Dr A Fernandez-Mato, Dr S Kondrat
15 February 2019
Many natural enzymes participate in chemical reactions which have commercial or medical value, and for which we have no good catalysts that can catalyse such reactions with the same precision and efficiency as enzymes.
Activating Carbon Dioxide Utilising Atmospheric Pressure Gas Plasma
Dr B Buckley, Dr F Iza
28 May 2019
This project will be part of the Doctoral Training Centre on Plasma interactions with Liquids. The Buckley group has embarked on a programme of research directed at carbon dioxide utilisation (CDU) and has reported initial efforts in the area.
Next Generation LA-ICP-MS Geoscience:
Dr A Managh, Dr M Horstwood
21 January 2019
Application details. Reference number. CENTA18-LU9. Start date. October 1st 2019. Closing date. January 21st 2019. Interview date.
Novel cyclic peptide constructs for targeted biomolecular imaging
Prof M Zanda, Dr S Butler
15 February 2019
Over 40 cyclic peptides are used in the clinic for a wide range of applications, such as somatostatin and ciclosporin. Cyclic peptides have enormous potential for disrupting protein-protein interactions and are therefore being pursued as drug candidates for treating a number of unmet medical needs.